Filing metadata

Accession number
0001209191-22-012344
Form type
Form 4
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Feb 23, 2022
Reporting period
Feb 18, 2022
Description
Insider transaction

Explore SEC Filings Hub